Piotr Popik
Piotr Popik
Institute of Pharmacology, Polish Acad. Sci. and Jagiellonian Univ., Krakow [ Cracow ], Poland
Verified email at cyf-kr.edu.pl - Homepage
Cited by
Cited by
Glutamate-based antidepressants: 20 years on
P Skolnick, P Popik, R Trullas
Trends in pharmacological sciences 30 (11), 563-569, 2009
Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression
P Skolnick, RT Layer, P Popik, G Nowak, IA Paul, R Trullas
Pharmacopsychiatry 29 (01), 23-26, 1996
Adenosine A3 receptor stimulation and cerebral ischemia
DKJE Von Lubitz, RCS Lin, P Popik, MF Carter, KA Jacobson
European journal of pharmacology 263 (1-2), 59-67, 1994
Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments
IA Paul, G Nowak, RT Layer, P Popik, P Skolnick
Journal of Pharmacology and Experimental Therapeutics 269 (1), 95-102, 1994
100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug.
P Popik, RT Layer, P Skolnick
Pharmacological Reviews 47 (2), 235-253, 1995
Low doses of oxytocin facilitate social recognition in rats
P Popik, J Vetulani, JM Van Ree
Psychopharmacology 106 (1), 71-74, 1992
Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study
M Siwek, D Dudek, IA Paul, M Sowa-Kućma, A Zięba, P Popik, A Pilc, ...
Journal of affective disorders 118 (1-3), 187-195, 2009
Antidepressant-like actions of DOV 21,947: a “triple” reuptake inhibitor
P Skolnick, P Popik, A Janowsky, B Beer, AS Lippa
European journal of pharmacology 461 (2-3), 99-104, 2003
Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests
IV Belozertseva, T Kos, P Popik, W Danysz, AY Bespalov
European neuropsychopharmacology 17 (3), 172-179, 2007
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans
A Bisaga, SD Comer, AS Ward, P Popik, HD Kleber, MW Fischman
Psychopharmacology 157 (1), 1-10, 2001
In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists
A Bisaga, P Popik
Drug and alcohol dependence 59 (1), 1-15, 2000
Oxytocin but not vasopressin facilities social recognition following injection into the medial preoptic area of the rat brain
P Popik, JM Van Ree
European Neuropsychopharmacology 1 (4), 555-560, 1991
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)
RT Layer, P Popik, T Olds, P Skolnick
Pharmacology Biochemistry and Behavior 52 (3), 621-627, 1995
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine
P Popik, W Danysz
Journal of Pharmacology and Experimental Therapeutics 280 (2), 854-865, 1997
Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist
P Popik, M Wrobel
Neuropharmacology 43 (8), 1210-1217, 2002
Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models
A Kłodzińska, E Chojnacka-Wojcik, A Pałucha, P Brański, P Popik, A Pilc
Neuropharmacology 38 (12), 1831-1839, 1999
Laughing rats are optimistic
R Rygula, H Pluta, P Popik
PLoS One 7 (12), e51959, 2012
“Broad spectrum” antidepressants: is more better for the treatment of depression?
P Skolnick, P Popik, A Janowsky, B Beer, AS Lippa
Life sciences 73 (25), 3175-3179, 2003
NMDA antagonist properties of the putative antiaddictive drug, ibogaine.
P Popik, RT Layer, LH Fossom, M Benveniste, B Geter-Douglass, ...
Journal of Pharmacology and experimental therapeutics 275 (2), 753-760, 1995
The putative anti-addictive drug ibogaine is a competitive inhibitor of [3 H] MK-801 binding to the NMDA receptor complex
P Popik, RT Layer, P Skolnick
Psychopharmacology 114 (4), 672-674, 1994
The system can't perform the operation now. Try again later.
Articles 1–20